222 related articles for article (PubMed ID: 31301576)
1. Cargo-less nanoparticles program innate immune cell responses to toll-like receptor activation.
Casey LM; Kakade S; Decker JT; Rose JA; Deans K; Shea LD; Pearson RM
Biomaterials; 2019 Oct; 218():119333. PubMed ID: 31301576
[TBL] [Abstract][Full Text] [Related]
2. Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma.
Goforth R; Salem AK; Zhu X; Miles S; Zhang XQ; Lee JH; Sandler AD
Cancer Immunol Immunother; 2009 Apr; 58(4):517-30. PubMed ID: 18719913
[TBL] [Abstract][Full Text] [Related]
3. Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulation.
Widmer J; Thauvin C; Mottas I; Nguyen VN; Delie F; Allémann E; Bourquin C
Int J Pharm; 2018 Jan; 535(1-2):444-451. PubMed ID: 29157965
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory Nanoparticles Mitigate Macrophage Inflammation via Inhibition of PAMP Interactions and Lactate-Mediated Functional Reprogramming of NF-κB and p38 MAPK.
Lasola JJM; Cottingham AL; Scotland BL; Truong N; Hong CC; Shapiro P; Pearson RM
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834256
[TBL] [Abstract][Full Text] [Related]
5. Characterization of innate responses induced by in ovo administration of encapsulated and free forms of ligands of Toll-like receptor 4 and 21 in chicken embryos.
Bavananthasivam J; Alkie TN; Matsuyama-Kato A; Hodgins DC; Sharif S
Res Vet Sci; 2019 Aug; 125():405-415. PubMed ID: 29126629
[TBL] [Abstract][Full Text] [Related]
6. Multiple Immunosuppressive Effects of CpG-c41 on Intracellular TLR-Mediated Inflammation.
Liu W; Yang X; Wang N; Fan S; Zhu Y; Zheng X; Li Y
Mediators Inflamm; 2017; 2017():6541729. PubMed ID: 28539706
[TBL] [Abstract][Full Text] [Related]
7. A family of helminth molecules that modulate innate cell responses via molecular mimicry of host antimicrobial peptides.
Robinson MW; Donnelly S; Hutchinson AT; To J; Taylor NL; Norton RS; Perugini MA; Dalton JP
PLoS Pathog; 2011 May; 7(5):e1002042. PubMed ID: 21589904
[TBL] [Abstract][Full Text] [Related]
8. Aberrant Toll receptor expression and endotoxin hypersensitivity in mice lacking a functional TGF-beta 1 signaling pathway.
McCartney-Francis N; Jin W; Wahl SM
J Immunol; 2004 Mar; 172(6):3814-21. PubMed ID: 15004187
[TBL] [Abstract][Full Text] [Related]
9. Biomaterial-Driven Immunomodulation: Cell Biology-Based Strategies to Mitigate Severe Inflammation and Sepsis.
Lasola JJM; Kamdem H; McDaniel MW; Pearson RM
Front Immunol; 2020; 11():1726. PubMed ID: 32849612
[TBL] [Abstract][Full Text] [Related]
10. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of Dual Toll-Like Receptor Agonists and Antigen in Poly(Lactic-Co-Glycolic) Acid/Polyethylenimine Cationic Hybrid Nanoparticles Promote Efficient
Ebrahimian M; Hashemi M; Maleki M; Hashemitabar G; Abnous K; Ramezani M; Haghparast A
Front Immunol; 2017; 8():1077. PubMed ID: 28955328
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Innate Responses Induced by PLGA Encapsulated- and Soluble TLR Ligands In Vitro and In Vivo in Chickens.
Alkie TN; Taha-Abdelaziz K; Barjesteh N; Bavananthasivam J; Hodgins DC; Sharif S
PLoS One; 2017; 12(1):e0169154. PubMed ID: 28045984
[TBL] [Abstract][Full Text] [Related]
13. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
Arsenault RJ; Kogut MH; He H
Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
[TBL] [Abstract][Full Text] [Related]
14. CUL4B negatively regulates Toll-like receptor-triggered proinflammatory responses by repressing Pten transcription.
Song Y; Li P; Qin L; Xu Z; Jiang B; Ma C; Shao C; Gong Y
Cell Mol Immunol; 2021 Feb; 18(2):339-349. PubMed ID: 31729464
[TBL] [Abstract][Full Text] [Related]
15. Encapsulation of two different TLR ligands into liposomes confer protective immunity and prevent tumor development.
Bayyurt B; Tincer G; Almacioglu K; Alpdundar E; Gursel M; Gursel I
J Control Release; 2017 Feb; 247():134-144. PubMed ID: 28069554
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial cell Toll-like receptor pathways in sepsis.
Khakpour S; Wilhelmsen K; Hellman J
Innate Immun; 2015 Nov; 21(8):827-46. PubMed ID: 26403174
[TBL] [Abstract][Full Text] [Related]
17. Immunotoxicity of poly (lactic-co-glycolic acid) nanoparticles: influence of surface properties on dendritic cell activation.
Barillet S; Fattal E; Mura S; Tsapis N; Pallardy M; Hillaireau H; Kerdine-Römer S
Nanotoxicology; 2019 Jun; 13(5):606-622. PubMed ID: 30760076
[TBL] [Abstract][Full Text] [Related]
18. Gold-quercetin nanoparticles prevent metabolic endotoxemia-induced kidney injury by regulating TLR4/NF-κB signaling and Nrf2 pathway in high fat diet fed mice.
Xu MX; Wang M; Yang WW
Int J Nanomedicine; 2017; 12():327-345. PubMed ID: 28115850
[TBL] [Abstract][Full Text] [Related]
19. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice.
Fujiwara M; Matoba T; Koga JI; Okahara A; Funamoto D; Nakano K; Tsutsui H; Egashira K
Cardiovasc Res; 2019 Jun; 115(7):1244-1255. PubMed ID: 30851101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
